Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 29, 2012
Senator Michael Bennet (D-CO): Innovative medical therapies aren't at war with our concerns about good health and they have to be regulated in a way that makes them available for the patients that need them.
On June 27, the Engelberg Center for Health Care Reform at Brookings hosted the State of Biomedical Innovation Conference in Washington, DC, with a keynote address and discussion with Senator Michael Bennet (D-CO). Designed to bring together diverse stakeholders and senior thought leaders from across the biomedical enterprise, this event engaged participants in discussion on the health of biomedical innovation in the United States, obstacles to innovation, policy options for overcoming those obstacles, and key metrics that can be used to evaluate whether the U.S. biomedical enterprise is effectively delivering new and innovative medical products to the patients who need them.